Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting
Links shared publicly online about this topic.
- 1,272total visits
Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple sclerosis portfolio of approved and investigational treatments will be presented at the 62nd Annual Meeting of the American Academy of Neurology taking place April 10 to 17, in Toronto, Canada.
View full resource at news-medical.net
Tags: Neurology, Multiple Sclerosis, Multiple Sclerosis Medication, Pregnancy, Rebif, Merck & Co., Merck KGaA
Most Recently Shared on April 1, 2010 at 12:09 pm By:
Pregnancy News: Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting: EMD Serono... http://bit.ly/d8ysYj
Advertisement
